BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways. Int J Mol Sci 2021;22:10791. [PMID: 34639132 DOI: 10.3390/ijms221910791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferraresi A, Isidoro C. Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics. Biomedicines 2022;11. [PMID: 36672560 DOI: 10.3390/biomedicines11010052] [Reference Citation Analysis]
2 Bouwmeester RN, Bormans EMG, Duineveld C, van Zuilen AD, van de Logt AE, Wetzels JFM, van de Kar NCAJ. COVID-19 vaccination and Atypical hemolytic uremic syndrome. Front Immunol 2022;13:1056153. [PMID: 36531998 DOI: 10.3389/fimmu.2022.1056153] [Reference Citation Analysis]
3 Allas GDO, Arizala JDR, Manalo RVM. COVID-19 Adenoviral Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), COVID-19-Related Thrombosis, and the Thrombotic Thrombocytopenic Syndromes. Hematol Rep 2022;14:358-72. [PMID: 36547234 DOI: 10.3390/hematolrep14040050] [Reference Citation Analysis]
4 Cari L, Naghavi Alhosseini M, Bergamo A, Pacor S, Pierno S, Sava G, Nocentini G. Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.967926] [Reference Citation Analysis]
5 Amiral J, Legros E, Vivant M, Rossi D, Renaud G. Vaccine induced thrombotic thrombocytopenia: development and reactivity of anti-platelet factor 4 antibodies and immune pathogenic mechanisms. Explor Immunol 2022. [DOI: 10.37349/ei.2022.00071] [Reference Citation Analysis]
6 Marietta M, Coluccio V, Luppi M. Potential mechanisms of vaccine-induced thrombosis. Eur J Intern Med 2022:S0953-6205(22)00274-6. [PMID: 35953336 DOI: 10.1016/j.ejim.2022.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Deng S, Liang H, Chen P, Li Y, Li Z, Fan S, Wu K, Li X, Chen W, Qin Y, Yi L, Chen J. Viral Vector Vaccine Development and Application during the COVID-19 Pandemic. Microorganisms 2022;10:1450. [DOI: 10.3390/microorganisms10071450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
8 Kurup D, Myers J, Schnell MJ. Current vaccine strategies against SARS-CoV-2: Promises and challenges. J Allergy Clin Immunol 2022;150:17-21. [PMID: 35618046 DOI: 10.1016/j.jaci.2022.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Romano D, Morescalchi F, Romano V, Semeraro F. COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion. Ocul Immunol Inflamm 2022;:1-3. [PMID: 35653651 DOI: 10.1080/09273948.2022.2079534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Garbuglia AR, Minosse C, Del Porto P. mRNA- and Adenovirus-Based Vaccines against SARS-CoV-2 in HIV-Positive People. Viruses 2022;14:748. [DOI: 10.3390/v14040748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dass SA, Balakrishnan V, Arifin N, Lim CSY, Nordin F, Tye GJ. The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic. Front Immunol 2022;13:833715. [PMID: 35242137 DOI: 10.3389/fimmu.2022.833715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
13 Pang X, Liu H, He X, Ji T, Zhu Y, Cui Y. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2. Front Immunol 2021;12:782335. [PMID: 35095856 DOI: 10.3389/fimmu.2021.782335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liu Y, Shao Z, Wang H. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Thromb Res 2022;209:75-9. [PMID: 34894531 DOI: 10.1016/j.thromres.2021.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Finsterer J, Nics S. Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine. Brain Hemorrhages 2021. [PMID: 34901793 DOI: 10.1016/j.hest.2021.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]